May 21, 2013
Wright & Filippis Exits Diabetes Market
Wright & Filippis, a Michigan-based home medical equipment provider, has announced that it will be exiting the diabetes market. The company has entered into an agreement to sell its diabetic supply business to US MED, another home medical equipment provider.
Share This Story
HME News Staff
Updated Tue May 21, 2013
ROCHESTER HILLS, Mich. – Wright & Filippis announced today that it has entered into an agreement to divest its diabetic supply business to US MED.
The reason: The company did not receive a contract to provide diabetes supplies as part of a national mail-order program that will go into effect July 1. US MED, along with 17 others, did receive a contract.
“Because of this change, we decided it was an appropriate time to sell our diabetes supply business to US MED,” stated AJ Filippis, president of Wright & Filippis, in a press release.
Due to the divestiture, Wright & Filippis will reduce its workforce by 3% over a 60-day period, according to the release. The company operates 35 locations and employs more than 900.
Wright & Filippis will now focus on its “traditional strengths” of orthotics and prosthetics, Filippis stated. Earlier this year, the company bought a controlling share of Carolina Orthotics & Prosthetics in North Charleston, S.C.
For its part, US MED may not be happy with the results of the mail-order program, but it’s committed to serving Wright & Filippis’ customers “with superior customer service,” stated CEO Zachary Schiffman in the release.
US MED is one of the largest providers of testing strips to Medicare beneficiaries in the nation. In 2011, the company received $25.7 million for strips, behind only Liberty Medical, DEGC Enterprises and Diabetes Care Club, according to data obtained from CMS and featured in the HME Databank.
Latest Media
ADS GETS ‘NEW EYES AND EARS’ TO REACH NEXT PHASE OF GROWTH
CARLSBAD, Calif. – Advanced Diabetes Supply has never been in a stronger position for growth, company officials say, and with new CEO Bill Mixon at the helm, they’re confident about its future. Leading ADS, a national distributor of specialty diabetes supplies, seems like a sharp divergence from Mixon’s previous role leading National Seating & Mobility, a provider…
ADS NAMES BILL MIXON CEO
CARLSBAD, Calif. – Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO. The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors. “Bill has provided valuable insight and support to…
Advanced Diabetes Sees Complement In US MED
Advanced Diabetes Supply (ADS) has acquired US Medical Supply (US MED) in a deal that will increase ADS’s visibility in the eastern United States and give it a large platform on which to grow. ADS and US MED are complementary businesses, with ADS focusing on insulin pumps and continuous glucose monitors and US MED having a strong digital marketing presence and a direct-to-consumer model. The acquisition is ADS’s first major deal since it was acquired by Court Square Capitol Partners in late 2020.
Read Next:
Diabetes, Products, Technology
Do I Need a CGM Prescription? Answers for People with Diabetes
Blog, Diabetes, Information, Research
Managing Diabetes and Depression: Strategies for Your Mental Health
Diabetes, Information
Managing Diabetes When You’re Sick: Essential Tips
For Healthcare Professionals
US MED® is America's primary choice for home delivery of quality medical supplies. Since 1996, over 1 million satisfied members have received disease state education and medical supplies from our highly trained customer service specialists. US MED®, the largest provider of Diabetic Supplies to the Medicare community, is licensed and accredited by Accreditation Commission for Health Care (ACHC) and maintains an A+ rating from the Better Business Bureau. We provide all products necessary to treat the Diabetes disease state, including therapies for its associated comorbidities. Our product portfolio includes, but is not limited to, the following: Diabetic testing strips, Continuous Glucose Monitors or CGMs, Insulin Pumps, Sleep Apnea and CPAP supplies, and Nebulizers.